Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Edgerton

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Oncogene|July 7, 2010
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cellsP M Das, A D Thor, S M Edgerton, et al.
Breast Cancer Research and Treatment|January 1, 1992
pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survivalA D Thor, F C Koerner, S M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
p53 gene mutations and protein accumulation in human ovarian cancerJ Kupryjańczyk, A D Thor, R Beauchamp, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitroIrina N Alimova, Bolin Liu, Zeying Fan, et al.
Carcinogenesis|January 14, 2010
Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulationXiaohe Yang, Shihe Yang, Christine McKimmey, et al.
The International Journal of Biochemistry & Cell Biology|August 30, 2002
Age-associated biomarker profiles of human breast cancerSerenella Eppenberger-Castori, Dan H Moore, Ann D Thor, et al.
Cell Cycle (Georgetown, Tex.)|May 15, 2009
Metformin induces unique biological and molecular responses in triple negative breast cancer cellsBolin Liu, Zeying Fan, Susan M Edgerton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assayP Eng Tan, C C Benz, C Dollbaum, et al.
Comparative Medicine|July 16, 2004
Mammary tumor heterogeneity in wt-ErbB-2 transgenic miceStanley Kosanke, Susan M Edgerton, Dan Moore, et al.
Cell Cycle (Georgetown, Tex.)|September 19, 2023
Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast CancerReema S Wahdan-Alaswad, Susan M Edgerton, Hyun Min Kim, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Oncogene|July 7, 2010
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cellsP M Das, A D Thor, S M Edgerton, et al.
Breast Cancer Research and Treatment|January 1, 1992
pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survivalA D Thor, F C Koerner, S M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
p53 gene mutations and protein accumulation in human ovarian cancerJ Kupryjańczyk, A D Thor, R Beauchamp, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitroIrina N Alimova, Bolin Liu, Zeying Fan, et al.
Carcinogenesis|January 14, 2010
Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulationXiaohe Yang, Shihe Yang, Christine McKimmey, et al.
The International Journal of Biochemistry & Cell Biology|August 30, 2002
Age-associated biomarker profiles of human breast cancerSerenella Eppenberger-Castori, Dan H Moore, Ann D Thor, et al.
Cell Cycle (Georgetown, Tex.)|May 15, 2009
Metformin induces unique biological and molecular responses in triple negative breast cancer cellsBolin Liu, Zeying Fan, Susan M Edgerton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assayP Eng Tan, C C Benz, C Dollbaum, et al.
Comparative Medicine|July 16, 2004
Mammary tumor heterogeneity in wt-ErbB-2 transgenic miceStanley Kosanke, Susan M Edgerton, Dan Moore, et al.
Cell Cycle (Georgetown, Tex.)|September 19, 2023
Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast CancerReema S Wahdan-Alaswad, Susan M Edgerton, Hyun Min Kim, et al.
Pageof 9